Back to Aptus Capital Advisors, LLC Aptus Capital Advisors, LLC

KAPAKAPA
6 quarters

Position history for Aptus Capital Advisors, LLCAptus Capital Advisors, LLC's holdings in KAIROS PHARMA LTD

Aptus Capital Advisors, LLC holds 44,286 shares of KAPA (KAIROS PHARMA LTD), worth $16,993 as of 2026-Q2. KAPA represents 0.0% of Aptus Capital Advisors, LLC's portfolio.

Current Value

$16,993

Current Shares

44,286

Total Value Change

-$24,468

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
44,286
0.0%
$16,9930.0%$0.38
0
2026-Q1
Unchanged
44,286
0.0%
$24,7560.0%$0.62
0
2025-Q4
Unchanged
44,286
0.0%
$31,4430.0%$0.70
0
2025-Q3
Unchanged
44,286
0.0%
$51,8150.0%$1.12
0
2025-Q2
Unchanged
44,286
0.0%
$31,3990.0%$0.67
0
2025-Q1
New
44,286
-
$41,4610.0%$0.92
28

Other major holders of KAPA: CITADEL ADVISORS LLC, VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used